These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 2972717)

  • 1. Isolation and characterization of microplasminogen. A low molecular weight form of plasminogen.
    Shi GY; Wu HL
    J Biol Chem; 1988 Nov; 263(32):17071-5. PubMed ID: 2972717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of human plasminogen by equimolar levels of streptokinase.
    Bajaj AP; Castellino FJ
    J Biol Chem; 1977 Jan; 252(2):492-8. PubMed ID: 137901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of human and bovine plasminogens by the microplasmin and streptokinase complex.
    Shi GY; Change BI; Wu DH; Ha YM; Wu HL
    Thromb Res; 1990 May; 58(3):317-29. PubMed ID: 2141198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure and function of microplasminogen: reconstitution of microplasminogen and microplasmin from isolated fragments.
    de los Santos T; Wang J; Reich E
    Ciba Found Symp; 1997; 212():66-76; discussion 76-83. PubMed ID: 9524764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Refolding, purification, and activation of miniplasminogen and microplasminogen isolated from E. coli inclusion bodies.
    Medynski D; Tuan M; Liu W; Wu S; Lin X
    Protein Expr Purif; 2007 Apr; 52(2):395-402. PubMed ID: 17126563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Covalent molecular weight approximately 92 000 hybrid plasminogen activator derived from human plasmin amino-terminal and urokinase carboxyl-terminal domains.
    Robbins KC; Tanaka Y
    Biochemistry; 1986 Jun; 25(12):3603-11. PubMed ID: 2941075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation and purification of microplasmin.
    Wu HL; Shi GY; Bender ML
    Proc Natl Acad Sci U S A; 1987 Dec; 84(23):8292-5. PubMed ID: 2960974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiostatin formation involves disulfide bond reduction and proteolysis in kringle 5 of plasmin.
    Stathakis P; Lay AJ; Fitzgerald M; Schlieker C; Matthias LJ; Hogg PJ
    J Biol Chem; 1999 Mar; 274(13):8910-6. PubMed ID: 10085135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of human plasminogen by urokinase. Partial characterization of a pre-activation peptide.
    Walther PJ; Steinman HM; Hill RL; McKee PA
    J Biol Chem; 1974 Feb; 249(4):1173-81. PubMed ID: 4273519
    [No Abstract]   [Full Text] [Related]  

  • 10. Isolation and characterization of alpha2-plasmin inhibitor from human plasma. A novel proteinase inhibitor which inhibits activator-induced clot lysis.
    Moroi M; Aoki N
    J Biol Chem; 1976 Oct; 251(19):5956-65. PubMed ID: 134998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two distinct pathways of the streptokinase-mediated activation of highly purified human plasminogen.
    McClintock DK; Englert ME; Dziobkowski C; Snedeker EH; Bell PH
    Biochemistry; 1974 Dec; 13(26):5334-44. PubMed ID: 4279693
    [No Abstract]   [Full Text] [Related]  

  • 12. Activation pathway of glu-plasminogen to Lys-plasmin by urokinase.
    Takada A; Takada Y
    Thromb Res; 1982 Sep; 27(6):671-7. PubMed ID: 6129717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary structure of porcine plasminogen. Isolation and characterization of CNBr-fragments and their alignment within the polypeptide chain.
    Brunisholz RA; Rickli EE
    Eur J Biochem; 1981 Sep; 119(1):15-22. PubMed ID: 7341239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deletion of Ile1 changes the mechanism of streptokinase: evidence for the molecular sexuality hypothesis.
    Wang S; Reed GL; Hedstrom L
    Biochemistry; 1999 Apr; 38(16):5232-40. PubMed ID: 10213631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A functionally active heavy chain derived from human high molecular weight urokinase.
    Sumi H; Robbins KC
    J Biol Chem; 1983 Jul; 258(13):8014-9. PubMed ID: 6345538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative characterization of the binding of plasminogen to intact fibrin clots, lysine-sepharose, and fibrin cleaved by plasmin.
    Bok RA; Mangel WF
    Biochemistry; 1985 Jun; 24(13):3279-86. PubMed ID: 3161540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure and formation of microplasmin.
    Wu HL; Shi GY; Wohl RC; Bender ML
    Proc Natl Acad Sci U S A; 1987 Dec; 84(24):8793-5. PubMed ID: 2962191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of fibrinogen and its cleavage products on the kinetics of plasminogen activation by urokinase and subsequent plasmin activity.
    Lucas MA; Straight DL; Fretto LJ; McKee PA
    J Biol Chem; 1983 Oct; 258(20):12171-7. PubMed ID: 6226655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of plasmin, microplasmin, and streptokinase-plasmin complex for the in vitro degradation of fibronectin and laminin- implications for vitreoretinal surgery.
    Hermel M; Dailey W; Hartzer MK
    Curr Eye Res; 2010 May; 35(5):419-24. PubMed ID: 20450255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Separation of human Glu-plasminogen, Lys-plasminogen and plasmin by high-performance affinity chromatography on Asahipak GS gel coupled with p-aminobenzamidine.
    Ito N; Noguchi K; Kazama M; Shimura K; Kasai K
    J Chromatogr; 1985 Nov; 348(1):199-204. PubMed ID: 2935552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.